This epidemiological family study (DOI:10.1177/1362361304040636) finds increased maternal depression and higher anxiety/OCD signals in relatives of children with PDDs, but no clear increase in objectively-validated autoimmune disorders; limitations (self-report, low control response rate, small subgroup N) weaken causal inferences and generalisability
Notes: autoimmune and psychiatric prevalence values plotted are the paper's reported summary percentages and onset fractions; estimated control/relative anxiety percents (for plotting) are reconstructed from tables and text; see inline citations below for precise numeric reporting and limitations described by the authors.
Strengths: epidemiologically-ascertained case sample (reduces clinic-referral bias), attempt to validate parental reports with GP records showing moderateβhigh parentβGP agreement (kappa ~0.4β1.0)
Key limitations / biases (that affect inference):
The authorsβ findings of a familial broad autism phenotype with elevated family anxiety/OCD signals and familial language/communication traits echo prior family/twin work demonstrating high heritability and subclinical familial traits (Bailey and Bolton family studies); however, the autoimmune-family link remains contested and inconsistent across studies β epidemiological, clinic-based and mechanistic immune studies produce mixed results and require larger, prospective, biologically-validated cohorts for resolution
Conclusion: evidence supports a familial broad autism phenotype (language/social subtler traits) and elevated maternal mood/anxiety disorders in PDD families; however, the autoimmune-family association is not supported in this epidemiological sample. Confidence: moderate for psychiatric familial aggregation signals; lowβmoderate for autoimmune negative finding because of small N and measurement limitations. What would change conclusions: larger, prospective family cohorts with structured diagnostic interviews, registry/medical-record linkage for lifetime diagnoses, and objective biomarker-based immune phenotyping would overturn or confirm the autoimmune claim; demonstration that control respondents were unbiased would strengthen current conclusions.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.